TG Therapeutics, Inc.
IT ˙ BIT ˙ US88322Q1085
34,00 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1TGTX / TG Therapeutics, Inc.
InstitutionAlliancebernstein L.p.
Latest Disclosed Ownership186,893 shares
Latest Disclosed Value $ 5,571,280
Alliancebernstein L.p. reports 1.16% increase in ownership of 1TGTX / TG Therapeutics, Inc.

On May 15, 2026 - Alliancebernstein L.p. filed a 13F-HR form disclosing ownership of 186,893 shares of TG Therapeutics, Inc. (IT:1TGTX) valued at $5,169,460 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 184,748 shares of TG Therapeutics, Inc.. This represents a change in shares of 1.16% during the quarter. The current value of the position is $6,354,362 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F TG THERAPEUTICS COM 88322Q108 186,893 2,145 1.16 5,571 1.16 0.0015
2026-02-17 2025-12-31 13F TG THERAPEUTICS COM 88322Q108 184,748 7,688 4.34 5,507 -13.90 0.0017
2025-11-14 2025-09-30 13F TG THERAPEUTICS COM 88322Q108 177,060 0 0.00 6,396 0.38 0.0020
2025-08-14 2025-06-30 13F TG THERAPEUTICS COM 88322Q108 177,060 7,650 4.52 6,372 -4.60 0.0021
2025-05-15 2025-03-31 13F TG THERAPEUTICS COM 88322Q108 169,410 -4,610 -2.65 6,680 27.51 0.0024
2025-02-12 2024-12-31 13F TG THERAPEUTICS COM 88322Q108 174,020 -19,550 -10.10 5,238 15.71 0.0018
2024-11-14 2024-09-30 13F TG THERAPEUTICS COM 88322Q108 193,570 31,700 19.58 4,528 57.24 0.0015
2024-08-14 2024-06-30 13F TG THERAPEUTICS COM 88322Q108 161,870 -5,350 -3.20 2,880 13.21 0.0010
2024-05-14 2024-03-31 13F TG THERAPEUTICS COM 88322Q108 167,220 0 0.00 2,543 -10.96 0.0009
2024-02-14 2023-12-31 13F TG THERAPEUTICS COM 88322Q108 167,220 4,400 2.70 2,856 109.85 0.0011
2023-11-14 2023-09-30 13F TG THERAPEUTICS COM 88322Q108 162,820 0 0.00 1,361 -66.35 0.0006
2023-08-15 2023-06-30 13F TG THERAPEUTICS COM 88322Q108 162,820 5,220 3.31 4,044 70.63 0.0017
2023-05-15 2023-03-31 13F TG THERAPEUTICS COM 88322Q108 157,600 -2,300 -1.44 2,370 25.33 0.0010
2023-02-15 2022-12-31 13F TG THERAPEUTICS COM 88322Q108 159,900 3,000 1.91 1,892 103.55 0.0009
2022-11-15 2022-09-30 13F TG THERAPEUTICS COM 88322Q108 156,900 0 0.00 929 39.28 0.0004
2022-08-15 2022-06-30 13F TG THERAPEUTICS COM 88322Q108 156,900 0 0.00 667 -55.29 0.0003
2022-05-13 2022-03-31 13F TG THERAPEUTICS COM 88322Q108 156,900 -60,550 -27.85 1,492 -63.89 0.0006
2022-02-14 2021-12-31 13F TG THERAPEUTICS COM 88322Q108 217,450 -20,671 -8.68 4,132 -47.86 0.0015
2021-11-10 2021-09-30 13F TG THERAPEUTICS COM 88322Q108 238,121 6,919 2.99 7,925 -11.63 0.0031
2021-07-30 2021-06-30 13F TG THERAPEUTICS COM 88322Q108 231,202 12,852 5.89 8,968 -14.79 0.0036
2021-05-06 2021-03-31 13F TG THERAPEUTICS COM 88322Q108 218,350 -62,734 -22.32 10,524 -28.03 0.0046
2021-02-08 2020-12-31 13F TG THERAPEUTICS COM 88322Q108 281,084 64,884 30.01 14,622 152.71 0.0069
2020-11-12 2020-09-30 13F TG THERAPEUTICS COM 88322Q108 216,200 -3,364 -1.53 5,786 35.28 0.0031
2020-08-13 2020-06-30 13F TG THERAPEUTICS COM 88322Q108 219,564 110,664 101.62 4,277 298.97 0.0025
2020-05-14 2020-03-31 13F TG THERAPEUTICS COM 88322Q108 108,900 -1,540 -1.39 1,072 -12.56 0.0008
2020-02-18 2019-12-31 13F TG THERAPEUTICS COM 88322Q108 110,440 0 0.00 1,226 97.74 0.0007
2019-11-14 2019-09-30 13F TG THERAPEUTICS COM 88322Q108 110,440 0 0.00 620 -35.08 0.0004
2019-08-14 2019-06-30 13F TG THERAPEUTICS COM 88322Q108 110,440 -12,200 -9.95 955 -3.14 0.0006
2019-05-14 2019-03-31 13F TG THERAPEUTICS COM 88322Q108 122,640 0 0.00 986 96.02 0.0006
2019-02-13 2018-12-31 13F TG THERAPEUTICS COM 88322Q108 122,640 40,100 48.58 503 8.87 0.0004
2018-11-08 2018-09-30 13F TG THERAPEUTICS COM 88322Q108 82,540 19,900 31.77 462 -43.93 0.0003
2018-08-13 2018-06-30 13F TG THERAPEUTICS COM 88322Q108 62,640 2,700 4.50 824 -3.17 0.0006
2018-05-14 2018-03-31 13F TG THERAPEUTICS COM 88322Q108 59,940 0 0.00 851 72.97 0.0006
2018-02-13 2017-12-31 13F TG THERAPEUTICS COM 88322Q108 59,940 0 0.00 492 -30.70 0.0004
2017-11-13 2017-09-30 13F TG THERAPEUTICS COM 88322Q108 59,940 0 0.00 710 17.94 0.0005
2017-08-10 2017-06-30 13F TG THERAPEUTICS COM 88322Q108 59,940 0 0.00 602 -13.75 0.0005
2017-05-11 2017-03-31 13F TG THERAPEUTICS COM 88322Q108 59,940 -1,000 -1.64 698 146.64 0.0006
2017-02-13 2016-12-31 13F TG THERAPEUTICS COM 88322Q108 60,940 0 0.00 283 -40.04 0.0002
2016-11-10 2016-09-30 13F TG THERAPEUTICS COM 88322Q108 60,940 -300 -0.49 472 27.22 0.0004
2016-08-11 2016-06-30 13F TG THERAPEUTICS COM 88322Q108 61,240 15,500 33.89 371 -4.87 0.0003
2016-05-13 2016-03-31 13F TG THERAPEUTICS COM 88322Q108 45,740 -11,400 -19.95 390 -42.82 0.0003
2016-02-16 2015-12-31 13F/A-1 TG THERAPEUTICS COM 88322Q108 57,140 7,100 14.19 682 35.32 0.0006
2016-02-12 2015-12-31 13F TG THERAPEUTICS COM 88322Q108 57,140 576
2015-11-13 2015-09-30 13F TG THERAPEUTICS COM 88322Q108 50,040 -160 -0.32 504 -39.50 0.0004
2015-08-14 2015-06-30 13F TG THERAPEUTICS COM 88322Q108 50,200 36,800 274.63 833 302.42 0.0007
2015-05-13 2015-03-31 13F TG THERAPEUTICS COM 88322Q108 13,400 500 3.88 207 1.47 0.0002
2015-02-13 2014-12-31 13F TG THERAPEUTICS COM 88322Q108 12,900 1,700 15.18 204 70.00 0.0002
2014-11-13 2014-09-30 13F TG THERAPEUTICS COM 88322Q108 11,200 0 0.00 120 14.29 0.0001
2014-08-13 2014-06-30 13F TG THERAPEUTICS COM 88322Q108 11,200 11,118 13,558.54 105 10,400.00 0.0001
2014-05-13 2014-03-31 13F TG THERAPEUTICS COM 88322Q108 82 -400 -82.99 1 -50.00 0.0000
2014-02-13 2013-12-31 13F TG THERAPEUTICS COM 88322Q108 482 -2,400 -83.28 2 -86.67 0.0000
2013-11-14 2013-09-30 13F TG THERAPEUTICS COM 88322Q108 2,882 -1,267 -30.54 15 -44.44 0.0000
2013-08-13 2013-06-30 13F TG THERAPEUTICS COM 88322Q108 4,149 4,149 27 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.